Patients undergoing Fludarabine based lymphodepletion prior to CAR-T cell therapy, for hematological malignancy research hub

Fludarabine exposure in patients undergoing Fludarabine based lymphodepletion prior to CAR-T cell therapy

This study looks at how a cancer drug called Fludarabine works in people getting ready for a special cell therapy. It aims to understand how much of the drug stays in the body and for how long, to help improve treatments for blood cancers.